V017-6765 Screening compound: 2-{4-[6-(3,4-dimethoxyphenyl)[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]piperazino}-N~1~-methyl-N~1~-phenylacetamide

V017-6765 Screening compound: 2-{4-[6-(3,4-dimethoxyphenyl)[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]piperazino}-N~1~-methyl-N~1~-phenylacetamide
V017-6765 Screening compound: 2-{4-[6-(3,4-dimethoxyphenyl)[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]piperazino}-N~1~-methyl-N~1~-phenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V017-6765
2-{4-[6-(3,4-dimethoxyphenyl)[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]piperazino}-N~1~-methyl-N~1~-phenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V017-6765

Molecular Formula

C26H29N7O3 (C26 H29 N7 O3)

Compound Name

2-{4-[6-(3,4-dimethoxyphenyl)[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]piperazino}-N~1~-methyl-N~1~-phenylacetamide

IUPAC name

2-{4-[6-(34-dimethoxyphenyl)-[124]triazolo[15-a]pyrimidin-7-yl]piperazin-1-yl}-N-methyl-N-phenylacetamide

SMILES

CN(C(CN(CC1)CCN1c(n1ncnc1nc1)c1-c(cc1)cc(OC)c1OC)=O)c1ccccc1

InChI

InChI=1S/C26H29N7O3/c1-30(20-7-5-4-6-8-20)24(34)17-31-11-13-32(14-12-31)25-21(16-27-26-28-18-29-33(25)26)19-9-10-22(35-2)23(15-19)36-3/h4-10,15-16,18H,11-14,17H2,1-3H3

InChI Key

UBOCIBBGQBMIGO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD10464114

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

487.56

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.802

Distribution Coefficient, logD

1.794

Water Solubility, LogSw

-2.50

Polar Surface Area

68.163

Acid Dissociation Constant (pKa)

22.61

Base Dissociation Constant (pKb)

5.64

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.77

V017-6765 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Immunological Library (6760 compounds)

Indoleamine 2,3-dioxygenase 1 Focused Library (5816 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer
  • Digestive system
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Immune system
Targets:
  • Others

References: we are preparing a list of scientific research reports with V017-6765 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V017-6765?
Check Price and Availability of V017-6765, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V017-6765 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V017-6765
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V017-6765
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V017-6765 available by request